Vivace Therapeutics’ $35 Million Series D Financing Round

Cooley advised Vivace Therapeutics, Inc., and Wilson Sonsini Goodrich & Rosati advised Vivace Therapeutics on the patent matters related to the transaction.Vivace Therapeutics, Inc. announced the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here